Please verify that you are a Healthcare Professional. Register for complete access to all the content!
Red flags signal inflammatory bowel disease in chi...
The use of red flags can help to identify inflammatory bowel disease (IBD) among children suffering from long-term abdominal pain, a clinical inv...
Linaclotide found effective for functional constip...
The outcomes of a study found Linaclotide to be well-tolerated and effective for functional constipation in children, as published in The Lancet...
2 minShockingly high H. pylori eradication rate with Ri...
Not just as monotherapy, oral Rifasutenizol capsules when combined with Rabeprazole enteric-coated tablets and Amoxicillin capsules (14-day tripl...
3 minPersonalized intermittent fasting routines found b...
The efficacy of patient-tailored Intermittent Fasting (IF) regimens holds promising results to combat Metabolic Dysfunction-Associated Steatotic...
2 minAncient meets Modern: Breakthrough treatment with...
Combining the time-tested efficacy of Traditional Chinese Medicine with contemporary pharmaceutical therapy, Yalan Chen et al. have introduced a...
2 minAlpha-lipoic acid associated with reduced hepatic...
A recent study has revealed favorable outcomes regarding the efficacy of alpha-lipoic acid (ALA) supplementation in combating hepatic steatosis a...
1 minFDA nods for Resmetirom, first-of-its-kind liver s...
Resmetirom is now FDA-approved for non-cirrhotic non-alcoholic steatohepatitis (NASH) with moderate to advanced liver scarring (fibrosi...
3 minLinaclotide use alters gut microbiota, Blautia gen...
According to the findings of a prospective study, the gut microbiota, particularly the Blautia genus, appears to be a crucial predictor of sympto...
2 minLinaclotide found effective for functional constip...
A recent clinical trial in ‘Journal of Pediatric Gastroenterology and Nutrition’ investigated the effectiveness and safety of Li...
1 minGMA use boosts survival rates in patients with sev...
In a prospective, open-label, nonrandomized study, granulocyte-monocyte/macrophage apheresis (GMA) demonstrated a lower-than-expected 90- and 180...
2 minTongxieyaofang eases IBS through CHRM3 regulation and gut barrier...
The decoction of Tongxieyaofang alleviates irritable bowel syndrome symptoms by influencing CHRM3 and gut barrier function.
Evaluation of antimicrobial concentrations in gastric tissues for...
Optimizing the levels and distribution of antibacterial drugs in the gastric mucosa is crucial for achieving effective H. pylori elimination rate...
Study reveals new findings for erosive esophagitis therapy
Potassium-competitive acid blockers are safe and effective, especially for 2-week short-term use, severe erosive esophagitis, and maintenance the...
Fexuprazan offers superior gastritis relief in two weeks compared...
Fexuprazan outperforms Rebamipide in treating acute gastritis over two weeks and matches its effectiveness over four weeks, thereby offering quic...
Long-term mortality in alcohol-related liver disease: Insights fr...
Patients with alcohol-related liver disease face a high risk of death due to liver disease long after diagnosis, with specific cancers like hepat...
Study: Tirzepatide for fight against steatohepatitis and liver fi...
Tirzepatide notably improves liver condition and fibrosis outcomes, and warrants consideration for inclusion in treatment strategies.
Do lifestyle changes lower the risk of mortality in NAFLD patient...
Adopting a healthy lifestyle drastically lowers all-cause and cardiovascular mortality risks in patients with nonalcoholic fatty liver disease, w...
Dialysis fatigue and recovery time remain unaffected by PPIs
Proton pump inhibitors do not affect recovery time or fatigue in hemodialysis patients, confirming their safety in managing these symptoms.
Xiangsha Liujunzi effective and safe for functional dyspepsia
Gastrointestinal health can be improved with Xiangsha Liujunzi decoction which enhances motility, protects the mucosa, and moderates inflammation...
Serum Angpt-2: Key diagnostic biomarker for diabetic kidney disea...
Serum Angiopoietin-2 shows immense potential as an early marker for diabetic kidney disease in children, supporting its future therapeutic prospe...
Takeda and Dr. Reddy’s join forces to launch Vonoprazan in India
Dr. Reddy’s has partnered with Takeda to launch Vonoprazan (VONO™), a novel acid blocker enhancing its GI treatment offerings in Indi...
The risk of chronic acid reflux can be reduced with minor dietary adjustments, as fruits, fish, and grains provide protective benefits.
This website uses cookies to help us give you the best experience when you visit.
By using this website you consent to our use of cookies. For more information please review our cookie policy.